Owing to high expression of survivin in most human cancers, such as prostate, ovary, lung, breast, stomach and liver cancers, and the fact that silencing of survivin leading to cell proliferation inhibition and apoptosis of tumor cells, this protein has been proposed to be a candidate therapeutic target against cancer [21,22,23,24,25]. Here, BIRC5 is linked to liver cancer.